LBO — SOUTHERN TENNESSEE MEDICAL CENTER
IRR: 20.2% | MOIC: 2.51x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
20.2%
IRR
2.51x
MOIC
$76.0M
Entry EV
$131.5M
Exit EV
$39.1M
Equity Invested
Sources & Uses
S&UTotal · $76.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $29.5M | 38.8% | |
| Sub Debt | $7.4M | 9.7% | |
| Equity | $39.1M | 51.5% | |
| Enterprise Value | $73.8M | 97.1% | |
| Transaction Fees | $2.2M | 2.9% | |
| Total Uses | $76.0M | 100.0% |
Interpretation
INTAt 2.51x MOIC and 20.2% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $12.5M |
| Exit Ev | $131.5M |
| Net Debt At Exit | $33.4M |
| Equity At Exit | $98.1M |
| Equity Invested | $39.1M |
| Total Value Created | $59.0M |
| Value From Growth | $54.0M |
| Value From Multiple | $3.7M |
| Value From Deleveraging | $3.5M |